Michael Rowley
Michael Rowley, Rome IT
Patent application number | Description | Published |
---|---|---|
20080221157 | Amide Derivatives as Inhibitors of Histone Deacetylase - The present invention relates to ketone derivatives that are inhibitors of histone deacetylase (HDAC). The compounds of the present invention are useful for treating cellular proliferative diseases, including cancer. Further, the compounds of the present invention are useful for treating neurodegenerative diseases, schizophrenia and stroke among other diseases. | 09-11-2008 |
20090048228 | Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors - The present invention relates to compounds of formula I: | 02-19-2009 |
20110034449 | N-SUBSTITUTED HYDROXYPYRIMIDINONE CARBOXAMIDE INHIBITORS OF HIV INTEGRASE - N-substituted 5-hydroxypyrimidin-6-one-4-carboxamides of formula: | 02-10-2011 |
Michael Rowley, Munster, IN US
Patent application number | Description | Published |
---|---|---|
20090200531 | Methods and apparatus for fencing and other outdoor structures - A fence system including a fence member and a fence rail having a first surface with a first slot and a second surface above the first surface and having a second slot aligned with the first slot. The fence member is inserted through the first slot and the second slot. | 08-13-2009 |
20100224847 | Fashion fence framework - A fence component with a first framework defining an opening and a second framework defining an opening, where the second framework faces the first framework. The fence component also has a panel between the first framework and the second framework, where the first opening faces a first side of the panel and the second opening faces a second side of the panel. | 09-09-2010 |
20110001104 | Attachment mechanism and fence system using the same - A fence system including a first post attached in the ground and a second post attached in the ground. The fence system also includes a rail coupled to the first post and the second post with a female member attachment mechanism and a lip. The fence system also includes a slat including a male member attachment mechanism with a flap and a locking mechanism defining a step. The slat is coupled to the rail such that the male member attachment mechanism is coupled to the female member attachment mechanism and the step abuts the lip. If a force is applied to remove the male member attachment mechanism from the female member attachment mechanism, the lip exerts a force on the step resisting the force applied to remove the male member attachment mechanism. | 01-06-2011 |
Michael Rowley, Pomezia (rome) IT
Patent application number | Description | Published |
---|---|---|
20090312241 | Macrocyclic Compounds as Antiviral Agents - The present invention relates to macrocyclic compounds of formula (I): wherein W, n, m, R | 12-17-2009 |
Michael Rowley, Axa IT
Patent application number | Description | Published |
---|---|---|
20090036443 | Thienopyrroles as antiviral agents - The present invention relates to thienopyrrole compounds of formula (I); wherein A, B, Y, Ar, n, Z and X | 02-05-2009 |
20090136449 | Tetracyclic Indole Derivatives as Antiviral Agents - The present invention relates to tetracyclic indole derivatives of formula (I); wherein Ar, D | 05-28-2009 |
Michael Rowley, Axa (rm) IT
Patent application number | Description | Published |
---|---|---|
20080275004 | N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase - N-substituted 5-hydroxypyrimidin-6-one-4-carboxamides of formula: | 11-06-2008 |
Michael Rowley, Axa (rome) IT
Patent application number | Description | Published |
---|---|---|
20080261938 | Tetracyclic Indole Derivatives as Antiviral Agents - The present invention relates to tetracyclic indole compounds of formula (I); wherein R | 10-23-2008 |
Michael Rowley, Luzern CH
Patent application number | Description | Published |
---|---|---|
20140328799 | COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES - The present invention is directed to compositions comprising inhibitors of hepatitis C virus (HCV) protease and one or more additional therapeutically effective agents. Uses of such compositions as HCV inhibitors and methods of treating infection by HCV by administration of such compositions are also disclosed. | 11-06-2014 |